Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 0904-7213

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 0904-7213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Ae6e79c0 A307 4888 B647 1b7be4cb9127 00)

Label for Acamprosate Calcium delayed-release tablets, 333 mg, unit dose, by Major Pharmaceuticals. The label shows the NDC 0904-7213-04, packaging size of 30 tablets, and prescription-only status. It includes storage instructions, dosage form as enteric-coated tablets, and manufacturer information: Glenmark Pharmaceuticals, USA, with distribution by Major Pharmaceuticals, Livonia, MI. Barcode and reference to the product being not child-resistant and for institutional use only are visible.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of Acamprosate Calcium showing its molecular arrangement including the calcium ion (Ca2+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.